BioCentury
ARTICLE | Clinical News

Smart Anti-L-Selectin Antibody: Began Phase IIa trial

November 22, 1999 8:00 AM UTC

Protein Design Labs Inc. (PDLI), Fremont, Calif. Product: Smart Anti-L-Selectin Antibody Business: Autoimmune/Inflammation Therapeutic category: Antibody, Immune modulation Target: Endothelial cells l...